KMB three-lens brief
Evidence-based stock research on KMB. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 13.4pp over 30 days. · Trading at 7% of its 52-week range — deep in the lower band.
- Trading at 7% of its 52-week range — deep in the lower band.
- Underperforming SPY by 13.4pp over 30 days.
- Analyst mean target $114.21 — 19% above current (14 analysts).
- Debt-to-equity of 371.3 — balance-sheet-heavy.
KMB closed at $96.06 (-1.64%) as of 2026-05-04. Market cap: $31.89B. P/E (trailing) 18.6. Positives: analyst mean target $114.21 — 19% above current (14 analysts).. Concerns: trading at 7% of its 52-week range — deep in the lower band.; underperforming SPY by 13.4pp over 30 days.. Last quarter: Revenue $4.16B, net income $665.00M, free cash flow $1.05B.
Why three lenses on KMB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine KMBacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/KMB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath KMB brief"></iframe>